US Recommends Pause For Johnson & Johnson COVID-19 Vaccines Over Clot Reports

The US Food and Drug Administration said it is asking states to temporarily stop using Johnson & Johnson’s Covid-19 vaccine after 6 people in the United States developed a rare blood clotting disorder.

The US Food and Drug Administration said the recommendation “results from an abundance of caution,” adding that adverse events seen in a handful of recipients appear extremely rare.

The US Food and Drug Administration said in a joint statement with the Centers for Disease Control and Prevention: This is important to ensure that the health care provider community is aware of the potential for these adverse events and can plan due to the unique treatment required with this type of blood clot.”

“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Anne Schuchat, Principal Deputy Director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement.